REGISTRATION OF THE COMBINATION OF SHARES OF DIGITALIST GROUP PLC, AND ADJUSTMENT OF THE MAXIMUM NUMBERS OF SHARES IN THE COMPANY AVAILABLE FOR SUBSCRIPTION UNDER THE COMPANY’S CONVERTIBLE LOAN INSTRUMENTS AND THE 2021 STOCK OPTION PROGRAM, AS WELL AS THE SUBSCRIPTION PRICES
August 15, 2025: Update
OTTAWA, ON, Aug. 15, 2025 /CNW/ - This outbreak investigation is ongoing. The public health notice will be updated as the investigation...
VANCOUVER, British Columbia, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. ("Westport") (TSX: WPRT / Nasdaq: WPRT) announces it has filed a preliminary short form base shelf prospectus (once filed in final form and received by the relevant Canadian securities regulatory authorities, the “Shelf Prospectus”) with the securities commissions in each of the provinces and territories of Canada, to replace its prior base shelf prospectus that expired on June 18, 2025.
The Board of Directors of Ensurge Micropower ASA (the "Company") has today resolved to grant a total of 385,000 incentive subscription rights to certain US employees in the Ensurge group. The grant was made under the Company's 2025 incentive subscription rights plan, as approved at the Extraordinary General Meeting held in the Company on 8 August 2025. The exercise price of the subscription rights is calculated to NOK 1.3294 per share.
BOCA RATON, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it now holds approximately 1,420,173 SOL and SOL equivalents on its balance sheet, inclusive of rewards generated through staking and onchain activities. The increase follows the Company’s acquisition of 110,000 SOL at an average price of $201.68, representing a total value of approximately $22 million.
The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...
The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...
Quarterly net revenues were RMB706.4million (US$98.6 million)1 Quarterlylidarshipments were352,095 units Quarterly net income was RMB44.1 million (US$6.2 million)
Growth in Revenue, Adjusted EBITDA, Connections, and Free Cash Flow
ATLANTA, Aug. 14, 2025 /PRNewswire/ -- KORE Group Holdings, Inc. (NYSE: KORE) ("KORE" or...
The Functional Foods Market is experiencing robust expansion, driven by rising consumer focus on health, wellness, and preventive nutrition. Growing demand for nutrient-enriched products,...
The growth of the Public Cloud Infrastructure Managed Service Market is driven by the increasing adoption of cloud technologies across industries, the rising need...
The growth of the Public Cloud Infrastructure Managed Service Market is driven by the increasing adoption of cloud technologies across industries, the rising need...